Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveBarclays Sets PPG Industries Price Target at $136

Live News EQUITY FLASH L impact Oct 13, 2026, 02:13 PM UTC

Barclays Sets PPG Industries Price Target at $136

Barclays announced a $136.00-per-share price target for PPG Industries.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

PPG

Related stories

Meta Platforms reports third-quarter revenue of $64.6 billion M impact | EQUITY | Oct 21, 2026, 08:12 PM UTC Banner Reports Third-Quarter Net Income of $47.7 Million Banner reported third-quarter 2026 net income of $47.7 million, or $1.36 per diluted share, compared with $48.9 million and $1.43 per share in the preceding quarter and $53.5 milli M impact | EQUITY | Oct 21, 2026, 08:01 PM UTC SEI Investments Reports Third-Quarter Revenue of $662M M impact | EQUITY | Oct 21, 2026, 08:01 PM UTC Nasdaq Leads Wall Street Higher as AI Sentiment Improves The tech-heavy Nasdaq led Wall Street higher at Wednesday’s close after quarterly results from SpaceX and Super Micro Computer improved investor appetite for AI-related stocks. Wea M impact | EQUITY | Oct 21, 2026, 08:00 PM UTC US session market picture: S&P 500 +0.57%, Nasdaq 100 +1.23%; EUR/USD -0.03%, WTI -0.26%, WBD leads volume US session market picture. US index futures: S and P futures is up 0.57 percent, Nasdaq futures is up 1.23 percent, Dow futures is up 0.55 percent and Russell futures is up 0.31 pe M impact | EQUITY | Oct 21, 2026, 08:00 PM UTC Capricor shares fall 11% as November FDA decision nears Capricor Therapeutics shares fell 11% Wednesday, extending weeks of declines as investors weighed the odds of FDA approval for its lead therapy, Deramiocel. The FDA is slated to de M impact | EQUITY | Oct 21, 2026, 07:52 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.